Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Full story
Read the full story at CNBC ↗
Continue reading this story on CNBC, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.